Skip to main content
Fig. 9 | Journal of Experimental & Clinical Cancer Research

Fig. 9

From: Enhancing immunotherapy efficacy with synergistic low-dose radiation in metastatic melanoma: current insights and prospects

Fig. 9

Tumor Treating Fields (TTFs) disrupt tumor mitosis and engage other mechanisms, including a potent synergistic antitumor immune response when combined with radiation therapy. The combination of TTFs and low-dose radiation therapy (LDRT) holds significant promise but requires detailed investigation. This area of research offers considerable potential for further exploration and development

Back to article page